A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.

The Ca(2+)-dependent cysteine protease calpain along with its endogenous inhibitor calpastatin is widely distributed. The interactions between calpain and calpastatin have been studied to better understand the nature of calpain inhibition by calpastatin, which can aid the design of small molecule inhibitors to calpain. Here we present the crystal structure of a complex between a calpastatin peptide and the calcium-binding domain VI of calpain. DIC19 is a 19 residue peptide, which corresponds to one of the three interacting domains of calpastatin, which is known to interact with domain VI of calpain. We present two crystal structures of DIC19 bound to domain VI of calpain, determined by molecular replacement methods to 2.5A and 2.2A resolution. In the process of crystallizing the inhibitor complex, a new native crystal form was identified which had the homodimer 2-fold axis along a crystallographic axis as opposed to the previously observed dimer in the asymmetric unit. The crystal structures of the native domain VI and its inhibitor PD150606 (3-(4-iodophenyl)-2-mercapto-(Z)-2-propenoic acid) complex were determined with the help of molecular replacement methods to 2.0A and 2.3A resolution, respectively. In addition, we built a homology model for the complex between domain IV and DIA19 peptide of calpastatin. Finally, we present a model for the calpastatin-inhibited calpain.

[1]  K. Blomgren,et al.  Calpastatin Is Up-regulated in Response to Hypoxia and Is a Suicide Substrate to Calpain after Neonatal Cerebral Hypoxia-Ischemia* , 1999, The Journal of Biological Chemistry.

[2]  Z. Jia,et al.  A Ca2+ Switch Aligns the Active Site of Calpain , 2002, Cell.

[3]  M. Cygler,et al.  Structure of a calpain Ca2+-binding domain reveals a novel EF-hand and Ca2+-induced conformational changes , 1997, Nature Structural Biology.

[4]  M. Maki,et al.  Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli. , 1988, The Journal of biological chemistry.

[5]  J M Thornton,et al.  Validation of protein models derived from experiment. , 1998, Current opinion in structural biology.

[6]  M. Maki,et al.  Amino-terminal conserved region in proteinase inhibitor domain of calpastatin potentiates its calpain inhibitory activity by interacting with calmodulin-like domain of the proteinase. , 1994, The Journal of biological chemistry.

[7]  R. Mellgren,et al.  m-Calpain requires DNA for activity on nuclear proteins at low calcium concentrations. , 1993, The Journal of biological chemistry.

[8]  M. Kubbutat,et al.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability , 1997, Molecular and cellular biology.

[9]  M. Spira,et al.  Real Time Imaging of Calcium-Induced Localized Proteolytic Activity after Axotomy and Its Relation to Growth Cone Formation , 1998, Neuron.

[10]  J Navaza,et al.  Implementation of molecular replacement in AMoRe. , 2001, Acta crystallographica. Section D, Biological crystallography.

[11]  T. Shearer,et al.  Activation of calpain in lens: a review and proposed mechanism. , 1997, Experimental eye research.

[12]  M. Maki,et al.  Preference of calcium‐dependent interactions between calmodulin‐like domains of calpain and calpastatin subdomains , 1995, FEBS letters.

[13]  E. Carafoli,et al.  The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte. , 1994, Cell calcium.

[14]  C. Kay,et al.  Ca2+‐Binding domain VI of rat calpain is a homodimer in solution: Hydrodynamic, crystallization and preliminary X‐ray diffraction studies , 1996, Protein science : a publication of the Protein Society.

[15]  K. Suzuki,et al.  Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A. , 2000, Advances in Experimental Medicine and Biology.

[16]  E. Lunney,et al.  An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[18]  A. Wlodawer,et al.  The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix. , 2000 .

[19]  Walter J. Chazin,et al.  High-resolution Solution Structure of Calcium-loaded Calbindin D9k , 1993 .

[20]  K. Moffat,et al.  The refined structure of vitamin D-dependent calcium-binding protein from bovine intestine. Molecular details, ion binding, and implications for the structure of other calcium-binding proteins. , 1986, The Journal of biological chemistry.

[21]  P. Greer,et al.  Disruption of the Murine Calpain Small Subunit Gene, Capn4: Calpain Is Essential for Embryonic Development but Not for Cell Growth and Division , 2000, Molecular and Cellular Biology.

[22]  L. DeLucas,et al.  Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding , 1997, Nature Structural Biology.

[23]  A Aszódi,et al.  Signal convergence on protein kinase A as a molecular correlate of learning. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[25]  K. Tanaka,et al.  Intracellular Ca2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). , 1980, Advances in enzyme regulation.

[26]  E. Melloni,et al.  Molecular and Functional Properties of a Calpain Activator Protein Specific for μ-Isoforms* , 1998, The Journal of Biological Chemistry.

[27]  D. Balcerzak,et al.  Potential m-calpain substrates during myoblast fusion. , 1999, Experimental cell research.

[28]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[29]  Z. Jia,et al.  Dissociation and Aggregation of Calpain in the Presence of Calcium* , 2001, The Journal of Biological Chemistry.

[30]  R. Bartus,et al.  Calpain as a novel target for treating acute neurodegenerative disorders. , 1995, Neurological research.

[31]  M. Cygler,et al.  Structure of apoptosis-linked protein ALG-2: insights into Ca2+-induced changes in penta-EF-hand proteins. , 2001, Structure.

[32]  Walter J. Chazin,et al.  High-resolution structure of calcium-loaded calbindin D9k. , 1993, Journal of molecular biology.

[33]  S. Barnoy,et al.  Association of calpain (Ca2+‐dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts , 1999, Journal of cellular biochemistry.

[34]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[35]  R. Huber,et al.  The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Suzuki,et al.  A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca(2+)-binding domain. , 1993, The Journal of biological chemistry.

[37]  E. Carafoli,et al.  Calpain: A Cytosolic Proteinase Active at the Membranes , 1997, The Journal of Membrane Biology.

[38]  Z. Jia,et al.  Crystal structure of calpain reveals the structural basis for Ca2+‐dependent protease activity and a novel mode of enzyme activation , 1999, The EMBO journal.

[39]  N. Brown,et al.  Studies of the active site of m-calpain and the interaction with calpastatin. , 1993, The Biochemical journal.

[40]  M. Kunimatsu,et al.  Postischemic Reperfusion Induces α‐Fodrin Proteolysis by m‐Calpain in the Synaptosome and Nucleus in Rat Brain , 1998, Journal of neurochemistry.

[41]  K. Wang,et al.  Calpain inhibition: an overview of its therapeutic potential. , 1994, Trends in pharmacological sciences.

[42]  K. Suzuki,et al.  Characterization of a human digestive tract-specific calpain, nCL-4, expressed in the baculovirus system. , 1999, Archives of biochemistry and biophysics.

[43]  M. Maki,et al.  Characterization of a functional domain of human calpastatin. , 1990, Biochemical and Biophysical Research Communications - BBRC.

[44]  K. Saigo,et al.  Calpain localization changes in coordination with actin-related cytoskeleton changes during early embryonic development of Drosophila. , 1995, The Journal of Biological Chemistry.

[45]  Kazuo Suzuki,et al.  Calpain Dissociates into Subunits in the Presence Ions , 1995 .

[46]  M. Maki,et al.  A growing family of the Ca2+-binding proteins with five EF-hand motifs. , 1997, The Biochemical journal.

[47]  E. Melloni,et al.  Phosphorylation of rat brain calpastatins by protein kinase C , 1999, FEBS letters.

[48]  R. Kretsinger.  EF-hands reach out , 1996, Nature Structural Biology.

[49]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .

[50]  M. Maki,et al.  Analysis of calcium-dependent interaction between amino-terminal conserved region of calpastatin functional domain and calmodulin-like domain of mu-calpain large subunit. , 1994, The Journal of biological chemistry.

[51]  E. Melloni,et al.  Changes in intracellular localization of calpastatin during calpain activation. , 1999, The Biochemical journal.

[52]  R. Bentley,et al.  Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. , 1999, Gastroenterology.